{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:15:29Z","timestamp":1774793729473,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["267788"],"award-info":[{"award-number":["267788"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["2737991"],"award-info":[{"award-number":["2737991"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Helsinki research"},{"DOI":"10.13039\/501100004012","name":"Jane and Aatos Erkko Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sigrid Juselius Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neulet.2016.11.008","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T02:01:34Z","timestamp":1478224894000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture"],"prefix":"10.1016","volume":"636","author":[{"given":"Timo T.","family":"My\u00f6h\u00e4nen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Norrbacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari H.","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.11.008_bib0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2016.11.008_bib0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2016.11.008_bib0015","doi-asserted-by":"crossref","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","article-title":"Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo","volume":"7","author":"Angot","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.11.008_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1937-6448(08)01406-8","article-title":"Molecular and cellular biology of synucleins","volume":"270","author":"Surguchov","year":"2008","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.neurobiolaging.2014.10.042","article-title":"Link between the SNCA gene and parkinsonism","volume":"36","author":"Xu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2016.11.008_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2016.11.008_bib0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2016.11.008_bib0040","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","article-title":"Altered proteasomal function in sporadic Parkinson's disease","volume":"179","author":"McNaught","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0050","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neulet.2016.11.008_bib0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"alpha-synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1471-4159.2010.06914.x","article-title":"Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease","volume":"115","author":"Xie","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","article-title":"Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated alpha-synuclein","volume":"9","author":"Bentea","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neulet.2016.11.008_bib0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0075","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.M114.592931","article-title":"Prolyl oligopeptidase enhances alpha-synuclein dimerization via direct protein-protein interaction","volume":"290","author":"Savolainen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0080","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.peptides.2008.05.005","article-title":"Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein","volume":"29","author":"Brandt","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.neulet.2016.11.008_bib0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.03.049","article-title":"Prolyl oligopeptidase colocalizes with alpha-synuclein, beta-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases","volume":"242","author":"Hannula","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.11.008_bib0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","article-title":"A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease","volume":"166","author":"My\u00f6h\u00e4nen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.04.003","article-title":"The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse","volume":"68C","author":"Savolainen","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2016.11.008_bib0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2014.09.026","article-title":"Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers","volume":"583C","author":"Dokleja","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2016.11.008_bib0105","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.20150956","article-title":"Therapeutic targeting of autophagy in neurodegenerative and infectious diseases","volume":"212","author":"Rubinsztein","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neulet.2016.11.008_bib0110","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/jm049503w","article-title":"A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors","volume":"47","author":"Jarho","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1742-7843.2011.00747.x","article-title":"Brain pharmacokinetics of two prolyl oligopeptidase inhibitors, JTP-4819 and KYP-2047, in the rat","volume":"109","author":"Jalkanen","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuint.2011.12.010","article-title":"The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum","volume":"60","author":"Jalkanen","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2016.11.008_bib0125","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology","volume":"30","author":"Gerard","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.11.008_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.12175","article-title":"Monoclonal antibodies selective for alpha-synuclein oligomers\/protofibrils recognize brain pathology in Lewy body disorders and alpha-synuclein transgenic mice with the disease-causing A30P mutation","volume":"126","author":"Fagerqvist","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.11.008_bib0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and alpha-Synuclein aggregation in parkinson's disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2016.11.008_bib0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson's disease: curse or blessing","volume":"124","author":"Ebrahimi-Fakhari","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2016.11.008_bib0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2008.05.005","article-title":"Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells","volume":"15","author":"Koch","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neulet.2016.11.008_bib0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI73938","article-title":"Development of autophagy inducers in clinical medicine","volume":"125","author":"Levine","year":"2015","journal-title":"J. Clin. Invest."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016308473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016308473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:51:03Z","timestamp":1589705463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016308473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":30,"alternative-id":["S0304394016308473"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.11.008","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}